• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌肝切除术后腹膜复发的危险因素及再切除治疗效果:一家三级医疗机构 1222 例肝切除病例回顾。

Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.

机构信息

Department of HPB Surgery and Liver Transplantation, University Surgical Cluster, National University Health System, Singapore, Singapore.

出版信息

Ann Surg Oncol. 2012 Jul;19(7):2246-55. doi: 10.1245/s10434-012-2260-3. Epub 2012 Mar 9.

DOI:10.1245/s10434-012-2260-3
PMID:22402812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3381119/
Abstract

BACKGROUND

Reports on the risk factors of peritoneal recurrence (PR) after liver resection for hepatocellular carcinoma are lacking. We examined the risk factors of PR after hepatectomy and the outcome of resected PR at our institution.

METHODS

We retrospectively reviewed the data from 1,222 patients who underwent hepatectomies for hepatocellular carcinoma in Samsung Medical Center from January 2006 to August 2010. We identified patients with PR and studied the risk factors and outcomes of resected PR.

RESULTS

The rate of PR was 3.0% (n=36). The mean±SD age of patients was 54.0±10.2 years. Among those with PR, 23 patients (63.9%) had unresectable disease and 13 patients (36.1%) had resectable disease. Multivariate analysis found that tumor size>50 mm, presence of microvascular invasion, bile duct invasion, and positive margins were significant risk factors of PR after liver resection. The median overall survival (OS) for resectable PR was 33.0 (28.0-61.6) months compared to 14.0 (6.8-21.2) months for unresectable PR (P=0.009). Cox regression analysis demonstrated that resected PR [hazard ratio (HR) 0.042, P = 0.001] and interval between hepatectomy and PR (>6 months) (HR 0.195, P=0.016) were positive prognostic factors for OS, while alfa-fetoprotein>200 ng/dl at detection of PR (HR 11.321, P=0.015) and serosal involvement of primary hepatocellular carcinoma (HR 25.616, P=0.007) were negative prognostic factors for OS.

CONCLUSIONS

We found that tumor size>50 mm, presence of microvascular invasion, bile duct invasion, and positive resection margins were significant risk factors of PR after liver resection. Selected patients with resected PR had significantly better OS.

摘要

背景

目前关于肝癌切除术后腹膜复发(PR)的危险因素的报道较少。我们在本机构检查了肝癌切除术后 PR 的危险因素和可切除 PR 的治疗结果。

方法

我们回顾性分析了 2006 年 1 月至 2010 年 8 月期间在三星医疗中心接受肝癌切除术的 1222 例患者的数据。我们确定了 PR 患者,并研究了可切除 PR 的危险因素和结果。

结果

PR 的发生率为 3.0%(n=36)。患者的平均年龄为 54.0±10.2 岁。在 PR 患者中,23 例(63.9%)为不可切除性疾病,13 例(36.1%)为可切除性疾病。多因素分析发现肿瘤直径>50mm、微血管侵犯、胆管侵犯和阳性切缘是肝癌切除术后 PR 的显著危险因素。可切除 PR 的中位总生存期(OS)为 33.0(28.0-61.6)个月,而不可切除 PR 的 OS 为 14.0(6.8-21.2)个月(P=0.009)。Cox 回归分析表明,可切除 PR(HR 0.042,P=0.001)和肝切除术后 PR 间隔时间(>6 个月)(HR 0.195,P=0.016)是 OS 的阳性预后因素,而 PR 时 AFP>200ng/dl(HR 11.321,P=0.015)和原发性肝癌的浆膜侵犯(HR 25.616,P=0.007)是 OS 的阴性预后因素。

结论

我们发现肿瘤直径>50mm、微血管侵犯、胆管侵犯和阳性切缘是肝癌切除术后 PR 的显著危险因素。选择性切除 PR 的患者 OS 显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d019/3381119/01e29760e5f9/10434_2012_2260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d019/3381119/9dcf8c1fbe63/10434_2012_2260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d019/3381119/01e29760e5f9/10434_2012_2260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d019/3381119/9dcf8c1fbe63/10434_2012_2260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d019/3381119/01e29760e5f9/10434_2012_2260_Fig2_HTML.jpg

相似文献

1
Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.肝癌肝切除术后腹膜复发的危险因素及再切除治疗效果:一家三级医疗机构 1222 例肝切除病例回顾。
Ann Surg Oncol. 2012 Jul;19(7):2246-55. doi: 10.1245/s10434-012-2260-3. Epub 2012 Mar 9.
2
Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.三级医疗机构中肝细胞癌肝切除术后肺和腹膜转移瘤切除术的临床病理因素及长期预后比较
Surgery. 2015 Apr;157(4):645-53. doi: 10.1016/j.surg.2014.07.024. Epub 2014 Nov 4.
3
Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.影响孤立性小肝细胞癌患者术后生存的预后因素。
Chin J Cancer. 2016 Aug 16;35(1):80. doi: 10.1186/s40880-016-0143-x.
4
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
5
[Surgical treatment of primary liver cancer:a report of 10 966 cases].[原发性肝癌的外科治疗:10966例报告]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
6
Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.肝细胞癌根治性肝切除术后浆膜侵犯与复发密切相关:214例连续病例的回顾性研究
Medicine (Baltimore). 2015 Mar;94(9):e602. doi: 10.1097/MD.0000000000000602.
7
Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.影响肝切除术后肝细胞癌预后的因素:单中心经验。
Korean J Intern Med. 2013 Jul;28(4):428-38. doi: 10.3904/kjim.2013.28.4.428. Epub 2013 Jul 1.
8
Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.复发性肝细胞癌患者再次行肝切除术的风险因素和预后。
Eur J Surg Oncol. 2019 Sep;45(9):1684-1690. doi: 10.1016/j.ejso.2019.04.008. Epub 2019 Apr 13.
9
Clinicopathological characteristics and prognostic factors in young patients after hepatectomy for hepatocellular carcinoma.青年肝细胞癌患者肝切除术后的临床病理特征及预后因素。
World J Surg Oncol. 2013 Mar 2;11:52. doi: 10.1186/1477-7819-11-52.
10
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.

引用本文的文献

1
A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.一种基于血清肿瘤坏死因子受体2(TNFR2)的模型可有效预测术前微血管侵犯,并对肝细胞癌的肿瘤复发风险进行分层。
BMC Gastroenterol. 2025 Aug 27;25(1):622. doi: 10.1186/s12876-025-04152-y.
2
Intratumoral and Peritumoral Radiomics Based on DCE-MRI for Prediction of Microvascular Invasion Grading in Solitary Hepatocellular Carcinoma (≤3 cm).基于动态对比增强磁共振成像的瘤内及瘤周放射组学预测孤立性肝细胞癌(≤3 cm)微血管侵犯分级
J Hepatocell Carcinoma. 2025 May 30;12:1083-1095. doi: 10.2147/JHC.S519578. eCollection 2025.
3

本文引用的文献

1
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
2
Current status of liver diseases in Korea: hepatocellular carcinoma.韩国肝脏疾病的现状:肝细胞癌
Korean J Hepatol. 2009 Dec;15 Suppl 6:S50-9. doi: 10.3350/kjhep.2009.15.S6.S50.
3
Cancer statistics in Korea: incidence, mortality and survival in 2005.韩国癌症统计数据:2005 年的发病率、死亡率和生存率。
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma.
基于套索法的列线图预测肝细胞癌根治性切除术后早期复发情况
J Hepatocell Carcinoma. 2025 Mar 12;12:539-552. doi: 10.2147/JHC.S510581. eCollection 2025.
4
Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.肝细胞癌患者细胞减灭术和腹腔热灌注化疗治疗腹膜转移的长期生存结果。
World J Surg Oncol. 2024 May 31;22(1):144. doi: 10.1186/s12957-024-03426-1.
5
Prevalence, patterns, risk factors and outcomes of peritoneal metastases after laparoscopic hepatectomy for hepatocellular carcinoma: a multicenter study from China.肝细胞癌腹腔镜肝切除术后腹膜转移的发生率、模式、危险因素及预后:一项来自中国的多中心研究
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):3-15. doi: 10.21037/hbsn-22-506. Epub 2023 Jun 8.
6
Surgical Treatment of Postoperative Abdominal Metastases of Hepatocellular Carcinoma: 10-Year Experience in a Single Center.肝细胞癌术后腹腔转移的外科治疗:单中心10年经验
Cancer Manag Res. 2021 Nov 20;13:8673-8683. doi: 10.2147/CMAR.S328250. eCollection 2021.
7
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.一种用于预测肝癌根治性肝切除术后早期复发的新型预后列线图的开发。
Ann Transl Med. 2021 Oct;9(20):1541. doi: 10.21037/atm-21-4837.
8
Usefulness and limitation of indocyanine green fluorescence for detection of peritoneal recurrence after hepatectomy for hepatocellular carcinoma: a case report.应用吲哚菁绿荧光法检测肝癌术后腹膜复发的价值及局限性:1 例报告。
BMC Surg. 2021 Mar 2;21(1):107. doi: 10.1186/s12893-021-01111-8.
9
Overview of spontaneous intraabdominal tumor hemorrhage: etiologies, imaging findings, and management.自发性腹腔内肿瘤出血概述:病因、影像学表现及处理。
Abdom Radiol (NY). 2021 Feb;46(2):427-440. doi: 10.1007/s00261-020-02663-8. Epub 2020 Jul 20.
10
SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.SOX4 在肝癌细胞中激活 CXCL12,从而调节体内内皮细胞的迁移和血管生成。
Oncogene. 2020 Jun;39(24):4695-4710. doi: 10.1038/s41388-020-1319-z. Epub 2020 May 13.
J Korean Med Sci. 2009 Dec;24(6):995-1003. doi: 10.3346/jkms.2009.24.6.995. Epub 2009 Nov 7.
4
Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis.肝细胞癌腹膜转移患者的临床表现与生存情况
J Gastroenterol Hepatol. 2009 May;24(5):815-20. doi: 10.1111/j.1440-1746.2009.05848.x.
5
Intraperitoneal metastasis of hepatocellular carcinoma after spontaneous rupture: a case report.肝细胞癌自发性破裂后腹膜转移:一例报告
World J Gastroenterol. 2008 Jun 28;14(24):3927-31. doi: 10.3748/wjg.14.3927.
6
Clinical features of hepatocellular carcinoma with extrahepatic metastases.伴有肝外转移的肝细胞癌的临床特征。
J Gastroenterol Hepatol. 2005 Nov;20(11):1781-7. doi: 10.1111/j.1440-1746.2005.03919.x.
7
Aggressive multimodal treatment for peritoneal dissemination and needle tract implantation of hepatocellular carcinoma: a case report.肝细胞癌腹膜播散和针道种植的积极多模式治疗:一例报告
Jpn J Clin Oncol. 2004 Sep;34(9):551-5. doi: 10.1093/jjco/hyh096.
8
Surgical treatment in a patient with multiple implanted intraperitoneal metastases after resection of ruptured large hepatocellular carcinoma.破裂的大肝细胞癌切除术后腹腔内多处转移患者的手术治疗
Hepatogastroenterology. 2004 Jan-Feb;51(55):239-42.
9
Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis.肝切除术后肝细胞癌腹膜种植转移灶的切除:危险因素及预后分析
World J Surg. 2004 Apr;28(4):382-6. doi: 10.1007/s00268-003-7319-7. Epub 2004 Mar 4.
10
Predictors and patterns of recurrence after resection of hepatocellular carcinoma.肝细胞癌切除术后复发的预测因素及模式
J Am Coll Surg. 2003 Nov;197(5):753-8. doi: 10.1016/j.jamcollsurg.2003.07.003.